[1]
D. Aggarwal, G. K. Randhawa, and R. Chander, “A prospective, randomized, open-label study to compare the efficacy and safety of metformin versus metformin and fluoxetine in patients of type 2 diabetes mellitus with mild depression”, Int J Basic Clin Pharmacol, vol. 14, no. 5, pp. 716–725, Aug. 2025.